154 related articles for article (PubMed ID: 2909371)
1. Actions of an estradiol-17-fatty acid ester in estrogen target tissues of the rat: comparison with other C-17 metabolites and a pharmacological C-17 ester.
MacLusky NJ; Larner JM; Hochberg RB
Endocrinology; 1989 Jan; 124(1):318-24. PubMed ID: 2909371
[TBL] [Abstract][Full Text] [Related]
2. The naturally occurring C-17 fatty acid esters of estradiol are long-acting estrogens.
Larner JM; MacLusky NJ; Hochberg RB
J Steroid Biochem; 1985 Mar; 22(3):407-13. PubMed ID: 3990290
[TBL] [Abstract][Full Text] [Related]
3. The interaction of C-17 esters of estradiol with the estrogen receptor.
Janocko L; Larner JM; Hochberg RB
Endocrinology; 1984 Apr; 114(4):1180-6. PubMed ID: 6705734
[TBL] [Abstract][Full Text] [Related]
4. Binding of estradiol-17-fatty acid esters to plasma proteins.
Larner JM; Rosner W; Hochberg RB
Endocrinology; 1987 Aug; 121(2):738-44. PubMed ID: 2439321
[TBL] [Abstract][Full Text] [Related]
5. Tissue differences in estrogen receptor dynamics: nuclear retention, rate of replenishment, and transient receptor loss vary in hypothalamus, pituitary, and uterus of C57BL/6J mice.
Bergman MD; Karelus K; Felicio LS; Nelson JF
Endocrinology; 1987 Dec; 121(6):2065-74. PubMed ID: 3678139
[TBL] [Abstract][Full Text] [Related]
6. Differential stimulation by 17 beta-estradiol and synthetic estrogens of progesterone-receptor and of translocation of estrogen-receptor in rat pituitary and uterus.
Leibl H; Spona J
Endocrinology; 1982 Jan; 110(1):265-71. PubMed ID: 7053987
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of estradiol fatty acid esters in man.
Hershcopf RJ; Bradlow HL; Fishman J; Swaneck GE; Larner JM; Hochberg RB
J Clin Endocrinol Metab; 1985 Dec; 61(6):1071-5. PubMed ID: 4055983
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of the fatty acid ester metabolites of corticoids.
Petrazzuoli M; Pahuja SL; Larner JM; Hochberg RB
Endocrinology; 1990 Aug; 127(2):555-9. PubMed ID: 1973648
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
Jordan VC; Gosden B
Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors.
Chwalisz K; Hegele-Hartung C; Fritzemeier KH; Beier HM; Elger W
Endocrinology; 1991 Jul; 129(1):312-22. PubMed ID: 2055191
[TBL] [Abstract][Full Text] [Related]
12. Actions and interactions of delta 5-androstene-3 beta, 17 beta-diol and 17 beta-estradiol in the immature rat uterus.
van Doorn LG; Poortman J; Thijssen JH; Schwarz F
Endocrinology; 1981 Apr; 108(4):1587-93. PubMed ID: 7472285
[TBL] [Abstract][Full Text] [Related]
13. Effects of estradiol-17 alpha on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth.
Clark JH; Williams M; Upchurch S; Eriksson H; Helton E; Markaverich BM
J Steroid Biochem; 1982 Feb; 16(2):323-8. PubMed ID: 7078167
[TBL] [Abstract][Full Text] [Related]
14. Estrogen to antiestrogen with a single methylene group resulting in an unusual steroidal selective estrogen receptor modulator.
Zhang JX; Labaree DC; Mor G; Hochberg RB
J Clin Endocrinol Metab; 2004 Jul; 89(7):3527-35. PubMed ID: 15240642
[TBL] [Abstract][Full Text] [Related]
15. A dose-response study on the estrogenic activity of benzophenone-2 on various endpoints in the serum, pituitary and uterus of female rats.
Schlecht C; Klammer H; Wuttke W; Jarry H
Arch Toxicol; 2006 Oct; 80(10):656-61. PubMed ID: 16586070
[TBL] [Abstract][Full Text] [Related]
16. Bimodal nuclear estrogen receptor binding: synchrony in athymic mouse uterus and human breast tumor xenografts.
Beckman WC; Hudspeth DA; Golding T; Hubbert L; Akkerman J; Korach KS
Endocrinology; 1989 Jun; 124(6):2651-8. PubMed ID: 2721439
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei.
Anderson JN; Peck EJ; Clark JH
Endocrinology; 1975 Jan; 96(1):160-7. PubMed ID: 162876
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat.
Murphy LJ; Friesen HG
Endocrinology; 1988 Jan; 122(1):325-32. PubMed ID: 3335211
[TBL] [Abstract][Full Text] [Related]
19. Effects of an estrogen antagonist on enzyme activities and [3H]estradiol nuclear binding in uterus, pituitary and brain.
Luine VN; McEwen BS
Endocrinology; 1977 Apr; 100(4):903-10. PubMed ID: 837886
[TBL] [Abstract][Full Text] [Related]
20. Multi-organic risk assessment of estrogenic properties of octyl-methoxycinnamate in vivo A 5-day sub-acute pharmacodynamic study with ovariectomized rats.
Klammer H; Schlecht C; Wuttke W; Jarry H
Toxicology; 2005 Nov; 215(1-2):90-6. PubMed ID: 16112788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
